MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
|Articles|September 16, 2015
Supplements and Featured Publications
- Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin
- Volume 21
- Issue 11 Suppl
eAPPENDIX 2. RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR DRUGS AND MAXIMUM DOSE LEVELS
Advertisement
eAPPENDIX 2. RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR DRUGS AND MAXIMUM DOSE LEVELS
Evaluated renin-angiotensin-aldosterone system (RAAS) inhibitor drugs and their maximum doses, listed in descending order of observed frequency at index: lisinopril, 40 mg; losartan, 100 mg; valsartan, 320 mg; benazepril, 80 mg; olmesartan, 40 mg; enalapril, 40 mg; spironolactone, 200 mg; irbesartan, 300 mg; ramipril, 10 mg; quinapril, 80 mg; telmisartan, 80 mg; candesartan, 32 mg; captopril, 450 mg; fosinopril, 40 mg; trandolapril, 8 mg; moexipril, 30 mg; aliskiren, 300 mg; eplerenone, 100 mg; perindopril, 8 mg; eprosartan, 800 mg; azilsartan, 80 mg.
Aliskiren/valsartan formulated 150 mg-160 mg (a partial dose of each of 2 RAAS inhibitor drugs) was considered a partial dose (submaximum).
Articles in this issue
about 11 years ago
eAPPENDIX 3. ADVERSE OUTCOME DEFINITIONSabout 11 years ago
eAPPENDIX 1. ICD-9 CODES USED FOR CLASSIFICATION OF COMORBIDITIESAdvertisement
Related to this article
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
This week in health equity and access: PMOS diagnosis, HIV lung cancer screening, transplant access, atopic dermatitis care, and value-based oncology.
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Advertisement
Advertisement
Trending on AJMC
1
Preparing Practices for the Next Era of Hepatitis B Care
2
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
3
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
4
CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs
5